Purple Biotech PPBT
NASDAQ PPBT
$1.51 -0.01 (-0.66%)
At close: Oct 2, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Consolidated Net Income (2014 - 2026)

Updated

Purple Biotech (PPBT) reported Consolidated Net Income of -$441,000 for Q2 2026, compared with $1.09 million a year earlier.

Analysis

Purple Biotech (PPBT) Consolidated Net Income (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Purple Biotech's Consolidated Net Income came in at $24.6 million, up 835.9% year-over-year; for FY2025, it came in at $26.49 million, up 264.0% from FY2024.

  • Consolidated Net Income has a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
  • By year, Consolidated Net Income came in at $7.28 million in FY2024 (-63.6%), $19.98 million in FY2023 (-8.2%), $21.76 million in FY2022 (+17.8%) and $18.47 million in FY2021 (-34.2%).
  • The Q2 2026 figure ranks as the lowest quarterly Consolidated Net Income in data going back to Q3 2014.
  • Year over year, Consolidated Net Income gained in 1 of the last six quarters, with an average decline of 51.0%.
  • The high point for year-over-year Consolidated Net Income in five years was Q3 2025 (growth of 95.4%); the low point was Q4 2024 (a decline of 91.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $89,000 (Q1 2026), $23.64 million (Q4 2025) and $1.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.51 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -237.00 Mn
10 Purple Biotech 247,575.07 189,575.07 - -441,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -441,000.00
Mar 31, 2026 89,000.00
Dec 31, 2025 23.64 Mn
Sep 30, 2025 1.31 Mn
Jun 30, 2025 1.09 Mn
Mar 31, 2025 456,000.00
Dec 31, 2024 415,000.00
Sep 30, 2024 668,000.00
Jun 30, 2024 2.42 Mn
Mar 31, 2024 3.78 Mn
Dec 31, 2023 4.86 Mn
Sep 30, 2023 5.06 Mn
Jun 30, 2023 5.16 Mn
Mar 31, 2023 4.90 Mn
Dec 31, 2022 6.04 Mn
Sep 30, 2022 4.85 Mn
Jun 30, 2022 3.55 Mn
Mar 31, 2022 7.32 Mn
Dec 31, 2021 5.11 Mn
Sep 30, 2021 3.15 Mn
API Access

Purple Biotech Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=PPBT&period=max&api_key=YOUR_API_KEY